Calcitonin gene-related peptide (CGRP) inhibitors -- a group of drugs commonly used to treat migraine -- were associated with decreased rates of acne and rosacea compared with drugs that did not ...
WhatAreMigraines.com launches as a neurologist-authored platform providing science-backed education on migraine treatments including CGRP inhibitors and Botox, addressing a critical gap in accessible, ...
In a small, nonrandomized controlled trial, the injectable calcitonin gene-related peptide (CGRP) inhibitor erenumab significantly reduced treatment-resistant flushing and erythema associated with ...
--Axsome Therapeutics, Inc., a biopharmaceutical company leading a new era in the treatment of central nervous system disorders, today announced that the EMERGE Phase 3 trial of SYMBRAVO ® in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback